News IDEXX Laboratories, Inc.

Equities

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2025-07-11 pm EDT			5-day change	1st Jan Change
533.37 ^USD	-1.43%		-2.49%	+29.01%

Jul. 10	AI Mania Masks Trade War Risks
Jul. 10	IDEXX Laboratories, Inc. Elects Joseph L. Hooley as an Independent Class III Director, as A Member of Its Audit Committee and Governance and Corporate Responsibility Committee, Effective July 10, 2025	CI

AI Mania Masks Trade War Risks	Jul. 10
IDEXX Laboratories, Inc. Elects Joseph L. Hooley as an Independent Class III Director, as A Member of Its Audit Committee and Governance and Corporate Responsibility Committee, Effective July 10, 2025	Jul. 10	CI
Idexx Laboratories elects Joseph L. (Jay) Hooley to board of directors	Jul. 10	RE
IDEXX Laboratories Elects Joseph L. (Jay) Hooley to Board of Directors	Jul. 10	BU
Stifel Adjusts Price Target on IDEXX Laboratories to $540 From $510, Maintains Hold Rating	Jul. 02	MT
Jefferies Initiates IDEXX Laboratories at Buy With $625 Price Target	Jul. 01	MT
IDEXX Laboratories, Inc.(NasdaqGS:IDXX) dropped from Russell 1000 Dynamic Index	Jun. 30	CI
IDEXX Laboratories to Release 2025 Second Quarter Financial Results	Jun. 24	BU
IDEXX Laboratories, Inc. Presents at Stifel Jaws & Paws Conference 2025, May-28-2025 10:55 AM	Jun. 20
IDEXX Laboratories, Inc., Q1 2025 Earnings Call, May 01, 2025	Jun. 19
Leerink Partners Adjusts IDEXX Laboratories Price Target to $580 From $515	Jun. 11	MT
IDEXX Laboratories, Inc. Announces the Launch of the Catalyst®? Cortisol Test	Jun. 05	CI
Idexx Laboratories - Launches Catalyst Cortisol Test For Diagnosing Addison's Disease And Managing Cushing's Syndrome In Dogs	Jun. 05	RE
Third Expansion of IDEXX's Catalyst Platform in Under a Year Delivers Critical Insights to Veterinarians Evaluating Canine Patients for Endocrine Disorders	Jun. 05	PR
Stifel Adjusts Price Target on IDEXX Laboratories to $510 From $460, Maintains Hold Rating	May. 19	MT
IDEXX Laboratories to Present at Stifel Conference and Announces 2025 Investor Day	May. 13	BU
BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $577 From $566, Maintains Outperform Rating	May. 12	MT
BTIG Raises Price Target on IDEXX Laboratories to $545 From $530, Maintains Buy Rating	May. 05	MT
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $558 From $548, Maintains Overweight Rating	May. 05	MT
Leerink Partners Adjusts IDEXX Laboratories Price Target to $515 From $500	May. 02	MT
Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.	May. 01	CI
IDEXX Laboratories raises annual profit view on strong demand for its pet diagnostics	May. 01	RE
IDEXX Laboratories Q1 Earnings, Revenue Increase; 2025 Outlook Raised	May. 01	MT
Earnings Flash (IDXX) IDEXX Laboratories Posts Q1 Revenue $998.4M, vs. FactSet Est of $997.1M	May. 01	MT
Earnings Flash (IDXX) IDEXX Laboratories Posts Q1 EPS $2.96, vs. FactSet Est of $2.85	May. 01	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Idexx Laboratories looks set for an upward trend

February 05, 2025 at 04:26 am EST